Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dobrin Nedelkov

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 31, 2025
An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-ITatiana Prokaeva, Shobini Jayaraman, Elena Klimtchuk, et al.
Plos One|March 26, 2014
Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassayPaul E Oran, Olgica Trenchevska, Dobrin Nedelkov, et al.
Proteomics|March 27, 2014
An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM)Scott Peterman, Eric E Niederkofler, David A Phillips, et al.
Research Square|May 4, 2026
Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's DiseaseZoe E Tsokolas, Isaac Asante, Amaryllis A Tsiknia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 16, 2022
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosisTatiana Prokaeva, Tracy Joshi, Elena S Klimtchuk, et al.
Clinical Biochemistry|January 15, 2013
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumBryan Krastins, Amol Prakash, David A Sarracino, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 31, 2025
An unusual phenotype of hereditary AApoAI amyloidosis caused by a novel Asp20Tyr substitution is linked to pH-dependent aggregation of apolipoprotein A-ITatiana Prokaeva, Shobini Jayaraman, Elena Klimtchuk, et al.
Plos One|March 26, 2014
Parallel workflow for high-throughput (>1,000 samples/day) quantitative analysis of human insulin-like growth factor 1 using mass spectrometric immunoassayPaul E Oran, Olgica Trenchevska, Dobrin Nedelkov, et al.
Proteomics|March 27, 2014
An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM)Scott Peterman, Eric E Niederkofler, David A Phillips, et al.
Research Square|May 4, 2026
Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's DiseaseZoe E Tsokolas, Isaac Asante, Amaryllis A Tsiknia, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 16, 2022
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosisTatiana Prokaeva, Tracy Joshi, Elena S Klimtchuk, et al.
Clinical Biochemistry|January 15, 2013
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumBryan Krastins, Amol Prakash, David A Sarracino, et al.
Pageof 8